Safety data of the 9-valent human papillomavirus vaccine (9vHPV) from the Vaccine Adverse Event Reporting System (VAERS) during the first 3 years of its licensure in the United States have shown neither new or unexpected safety signals, nor unusual reporting patterns for clinically important adverse events (AEs), as reported in a study. Furthermore, the safety profile of the vaccine is similar to that of its quadrivalent predecessor (4vHPV).
In neonates at risk of congenital adrenal hyperplasia, prenatal dexamethasone exposure appears to reduce virilization but exerts no effect on physical outcomes, cognitive functions, behavioural problems and temperament, according to the results of a meta-analysis.
Use of antithyroid drug (ATD) therapy in early pregnancy appears to increase the risk of birth defects, suggesting that abnormal maternal thyroid function is not a major risk factor for birth defects, a recent study has shown.
The presence of maternal stress or anxiety disorders prior to or following childbirth may be detrimental to children, bearing an increased hazard of fractures in early life, as shown in a recent study.
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.